Bank Of Montreal Enanta Pharmaceuticals Inc Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$38.82 - $54.59 $2.6 Million - $3.66 Million	66,967 New	66,967 $2.71 Million
Q2 2022 Aug 11, 2022	BUY	$38.13 - $76.93 $2.03 Million - $4.11 Million	53,362 Added 960.09%	58,920 $2.69 Million
Q1 2022 May 12, 2022	BUY	$56.06 - $74.11 $38,681 - $51,135	690 Added 14.17%	5,558 $393,000
Q4 2021 Feb 11, 2022	SELL	$60.19 - $97.37 $77,464 - $125,315	-1,287 Reduced 20.91%	4,868 $366,000
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $17,023 - $24,339	-415 Reduced 6.32%	6,155 $350,000
Q2 2021 Aug 12, 2021	BUY	$43.76 - $53.11 $287,503 - $348,932	6,570 New	6,570 $318,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.